Your AI found $4,200
your morning huddle missed.
Diagnose ingests panoramic radiographs, CBCT scans, and intraoral photos — then returns prioritized treatment recommendations ranked by clinical urgency, insurance viability, and patient acceptance probability. Before your hygienist finishes probing.
The numbers your current workflow doesn't show you.
when AI-annotated findings are shown to patients during consultation
Practices see 10–20% lift within months of deployment.
One DSO increased treatment planning rates from 11% to 30% for targeted providers within a single year.
AI-assisted radiograph analysis vs. unaided clinical review
Presented at 2023 ADA Smilecon Conference.
AI model outperformed periodontal specialists: AUROC 94.2% vs 85.6% (p < 0.01) in 2025 multicenter study.
based on average 59% case acceptance with AI-surfaced findings
499% ROI. Pays for itself in under 2.5 months.
With an average case acceptance rate of 59%, AI-driven improvements translate to an extra $2,600 in revenue per month per provider.
Six metrics. One toggle. See exactly what you're leaving behind.
See Full Benchmark ReportData sourced from Diagnose customer benchmarks, ADA Smilecon 2023, and Levin Group industry analysis.
Run your numbers.
No email required to see the math.
Enter three data points. Get a personalized revenue-impact estimate based on your actual practice size and current performance.
Enter 1 for solo practice
Industry average: 42–59%
Enter your practice data to see your personalized impact estimate
Three operators. Three use cases. One pattern.
"We rolled Diagnose across 38 locations last Q3. By week six, our treatment planning rate for crowns was up 22 points. The diagnostic consistency data alone justified the contract renewal."
"I was losing perio cases every week — patients walking out thinking they just needed a cleaning. Diagnose surfaces the bone loss visually, right in front of the patient, during the appointment. Case acceptance on SRP went from 51% to 83% in 90 days."
"I benchmark case acceptance rates across 14 practices. Before Diagnose, the spread was 28 to 71 percent — same market, totally inconsistent. After standardizing on Diagnose, the floor came up to 58 and the ceiling hit 88. The variance collapsed."
The findings are already there.
Diagnose finds them first.
Deploy across one location or one hundred. Standardize diagnostic consistency, surface missed revenue, and close more treatment plans — starting this week.